This publication is provided for historical reference only and the information may be out of date.
Patient Population Information
Age (descriptive statistics)
Age subgroup analysis in paper: yes/no
Gender subgroup analysis in paper: yes/no
Race subgroup analysis in paper: yes/no
Total number of patients in analysis
Type of dialysis population: #pre-dialysis, #dialysis (percentages will be automatically calculated cells)
Type of dialysis - # HD, #PD
Patient inclusion exclusion criteria - to be provided to TAG only for information
Treatment information
EPO yes/no
IV iron yes/no
Oral iron yes/no
Androgen yes/no
Transfusion yes/no
Other free text
Pediatric studies:
Nutritional supplementation yes/no [when defined as nutrition given by IV, NGT (nasogastric tube), NJT (nasojejunal tube), G-tube (gastrostomy tube), J-tube (jejunostomy tube)]
Growth hormone yes/no
Group Hematocrit description table
Summary hematocrit value
Hematocrit summary statistic (mean versus median)
SD hematocrit
Range
Number of patients in group
Outcome information
- Functional Status - issues of various outcome assessment tools used and appropriate
intermediate outcomes - Quality of life - KD QOL etc
- Survival
- Blood transfusions - various ways of reporting
% pts requiring transfusion
number of transfusions needed (units) - Hospitalization - various dimensions of this outcome to consider
Number of hospital days
Number of overall hospitalizations
Number of hospitalizations for a specific problem - Treatment related morbidity - rate of new or worsened hypertension, vascular access thrombosis, cardiovascular events, any others? (seizures, etc...)
- Growth - height, weight, percentile, standard deviation score, head circumference
- Development - Stanford-Binet score, Bailey score, normal vs. delayed
- School Performance - within normal limits vs. special needs Regularly attend school - able vs. unable vs. part-time
Publication Details
Copyright
Publisher
Agency for Healthcare Research and Quality (US), Rockville (MD)
NLM Citation
Flamm CR, Aronson N, Bohn R, et al. Use of Epoetin for Anemia in Chronic Renal Failure. Rockville (MD): Agency for Healthcare Research and Quality (US); 2001 Aug. (Evidence Reports/Technology Assessments, No. 29.) Appendix B. Data Abstraction Forms: Renal.